The sphingotest® DPP3 is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of dipeptidyl peptidase 3 in human EDTA plasma.
Dipeptidyl peptidase…
The sphingotest® bio-ADM® is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of bioactive Adrenomedullin 1-52 in human EDTA plasma.
Bioactive…
sphingotest® penKid® is a non-automated immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of Proenkephalin A 119-159 in human EDTA plasma.
Proenkephalin A 119-159…
A new study and real-world data on the kidney function biomarker penKid underline its potential to monitor kidney function during acute kidney injury (AKI) and RRT and to support liberation decisions…
The MDA solidifies the partnership between Boditech and SphingoTec, aiming to support the successful commercialization of the assay for the biomarker penKid on the AFIAS platforms.
The sphingotest® Lightning is a reagent intended for quantitative in vitro diagnostics and used for automated chemiluminescence measurement of sphingotest® immunoluminometric assays (ILMA) using…
For higher throughput, IVD tests for SphingoTec’s proprietary biomarkers for critical care and preventive medicine are made available as sphingotest® microtiterplate assays.
Bioactive Adrenomedullin (bio-ADM), is a dynamic biomarker for the real time assessment of endothelial function. Loss of endothelial function is causing the formation of edema, shock and subsequent…
PenKid Whitepaper
The whitepaper covers practical insights on the AKI diagnostics and highlights the scientific evidence for penKid, a kidney function biomarker.
Click here to download the…
Our skilled international team has a breadth of experience in life sciences, disease biology, biotechnology, and clinical in vitro diagnostics and is dedicated to supporting the medical community and…
